MedTrace Logo

Role of Low Dose Injectable Progesterone in Triggering Ovulation

NCT06928844 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-04-16

No results posted yet for this study

Summary

The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.

Conditions

  • Low Dose
  • Progesterone
  • Triggering Ovulation

Interventions

DRUG

Progesterone

Women will receive low dose progesterone 5 mg intramuscularly as a study group. (Letrozole 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).

DRUG

Placebo

Women will receive placebo as a control group. (Placebo 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).

Sponsors & Collaborators

  • The General Authority for Teaching Hospitals and Institutes

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2025-08-01
Completion
2025-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06928844 on ClinicalTrials.gov